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SUMMARY 
 
Guidelines advise performing a CT head scan for all anticoagulated head injured patients, but the risk 
of intracranial haemorrhage (ICH) after a minor head injury is unclear. We conducted a systematic 
review and meta-analysis to determine the incidence of ICH in anticoagulated patients presenting 
with a minor head injury and a GCS score of 15. We followed Meta-Analyses and Systematic Reviews 
of Observational Studies guidelines. We included all prospective studies recruiting consecutive 
anticoagulated emergency patients presenting with a head injury. Anticoagulation included vitamin-
K antagonists (warfarin, fluindione), direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, 
and edoxaban) and low molecular weight heparin. A total of five studies (including 4,080 
anticoagulated patients with a GCS score of 15) were included in the analysis. The majority of 
patients took vitamin K antagonists (98.3%). There was significant heterogeneity between studies 
with regards to mechanism of injury and methods. The random effects pooled incidence of ICH was 
8.9% (95% CI 5.0-13.8%). In conclusion, around 9% of patients on vitamin K antagonists with a minor 
head injury develop ICH. There is little data on the risk of traumatic intracranial bleeding in patients 
who are GSC 15 post head injury and are prescribed a direct oral anticoagulant.  
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INTRODUCTION 
 
 Head injury is one of the leading causes of emergency department (ED) visits(Mannix et al. 
2013). A large number of head injuries are due to falls in the elderly population(Pickett et al., 2001). 
Hospital admissions following head injury are rising, particularly among the elderly(Fu et al., 2015). 
The rate of anticoagulant use in this population has been steadily increasing. In particular, direct oral 
anticoagulant (DOAC) prescriptions have increased among the elderly, mostly as a means of stroke 
prophylaxis in atrial fibrillation patients(Xu et al., 2013). While anticoagulants prevent ischemic 
stroke, paradoxically, they are associated with a small risk of haemorrhagic stroke. Therefore, 
anticoagulated patients with head trauma may be at a higher risk of intracranial haemorrhage (ICH) 
than others who are not prescribed an anticoagulant.  
Head injured patients often undergo head computed tomography (CT) scanning(Ip et al., 
2015). Guidelines for requesting a head CT were developed to determine which patients would 
benefit most from CT scan, to rationalize resources(Haydel et al., 2000). During derivation, decision 
rules for determining who requires head CT after head injury excluded anticoagulated patients, and 
these guidelines now recommend CT head scans for all anticoagulated patients with a head 
injury(Hoffman et al. 1998; Steill et al. 2001).  This is most controversial for anticoagulated patients 
who have a Glasgow Coma Score (GCS) of 15 in the ED. The risk of ICH among anticoagulated 
patients with a minor head injury (GSC 15) remains unclear.  
The objective of this study was to determine the incidence of ICH in anticoagulated patients 
presenting to the ED with minor head injury.  
 
 
 
 
 METHODS 
The MOOSE (Meta-analysis of Observational Studies in Epidemiology) methodological approach was 
followed for the completion of this meta-analysis(Stroup et al. 2000). The protocol was registered 
with PROSPERO (CRD42015025448). 
 
Search Strategy  
 Pubmed, EMBASE (via OVID 1974-2017), Cochrane, and Database of Abstracts of Reviews of 
Effects databases were searched for articles relevant to anticoagulated ED patients with head 
injuries, on 1st July 2015. An identical search was re-run and the results updated on March 1th, 2018. 
Individual bibliographies of full papers and reviews captured in the search were examined for 
additional relevant references that may have been missed in the electronic search. The Pubmed and 
EMBASE search strategies are shown in Appendix 1. An additional search was conducted on Google 
Scholar. Researchers in the field were contacted for information on any unpublished data. 
Conference abstracts from academic emergency medicine research conferences were hand 
searched. 
The initial database search results were independently reviewed by MT and ME, while the 
updated search was independently reviewed by AW and HM. Potentially eligible papers were 
identified and the full texts reviewed by a minimum of three authors, (including KdW). These authors 
met to agree on inclusion or exclusion of each full text.  
 
Inclusion and Exclusion  
 The authors followed strict inclusion and exclusion criteria. Included studies had to 
be prospective studies which identified consecutive ED head injured patients who were prescribed 
an anticoagulant in the community. Included studies had to report the incidence of diagnosed ICH 
among unselected anticoagulated head injured patients. Vitamin K antagonists, dabigatran, 
edoxaban, apixaban, rivaroxaban, fondaparinux and low molecular weight heparin were all 
 considered anticoagulants. We included conference abstracts, unpublished and published studies. 
There were no language restrictions. Papers in a language other than English were forwarded to a 
colleague who was fluent in the language for translation.  
Retrospective studies were excluded because of the difficulties of identifying all head injured 
patients (rather than those who sustained major trauma), of identifying patients who were 
anticoagulant users, and because of lack of standardized diagnostic assessment(Nagurney et al. 
2005). To avoid inclusion of anomalous results, studies reporting on less than 20 anticoagulated head 
injured patients were excluded. Studies reporting only on a subset of anticoagulated ED patients (for 
example only those who were referred to the trauma service) were excluded, as these studies would 
not reflect the true incidence of ICH found among consecutive ED patients, the majority of whom are 
discharged directly home. We excluded cohort studies reporting only the incidence of delayed 
bleeding (not ICH on initial ED assessment). We excluded studies reporting on patients prescribed 
antiplatelet medication alone.  
Where it was unclear from the manuscript, we contacted the authors to confirm whether 
the study met inclusion criteria. We used a systematic approach for contact by email. An email letter 
was sent to the corresponding author, followed two weeks later by a letter to both the first and last 
authors. If there was still no response, then a third and final email was sent.  
 
Data extraction  
 The four reviewers independently abstracted data from the eligible studies using a table 
created by all those involved. Any discrepancy was resolved by consensus review. If the data were 
unclear, the primary authors were contacted for clarification.  
We contacted the authors of all included studies to obtain separate data for patients who 
presented to the ED with a GCS of 15 at ED triage. We excluded any patient with a GCS of 14 or less 
at ED triage. Data were extracted on total number of GCS 15, anticoagulated head injured ED 
patients, the number of these patients diagnosed with ICH on initial presentation to ED and number 
 of patients diagnosed with ICH during follow up. Demographic data extracted included: year(s) of 
study, country, type of study, mechanism of injury, definition of the primary outcome and protocol 
for the diagnosis of ICH.  
The primary outcome was the proportion of GCS 15, anticoagulated head injured ED patients 
who were diagnosed with ICH either at the initial presentation to the ED or during study follow up. 
tĞƵƐĞĚĞĂĐŚƐƚƵĚǇ ?ƐƉƌŝŵĂƌǇŽƵƚĐŽŵĞĚĞĨŝŶŝƚŝŽŶŽĨ/, ? 
 
Assessment of study quality  
 A risk of bias assessment was completed independently by AW, HM and KdW. Discrepancies 
were resolved by consensus. The  “Tool to Assess Risk of Bias in Longitudinal Symptom Research 
^ƚƵĚŝĞƐŝŵĞĚĂƚƚŚĞ'ĞŶĞƌĂůWŽƉƵůĂƚŝŽŶ ?, created by the Clarity group at McMaster was used 
(Clarity, accessed 2018). The tool reviews three domains; whether the source population is 
representative of the general population, if the assessment of the outcome is accurate both at 
baseline and follow-up, and if there is missing data.  
 
Statistical Analysis  
The data were reviewed for statistical heterogeneity with I2 and clinical heterogeneity was assessed 
by consensus between authors on similarity of populations and diagnostic strategies. Meta-analysis 
was performed using the random effects model. We did not construct funnel plots to assess for 
publication bias as these have been shown to be inaccurate for studies addressing proportions, and 
may cross the 0% or 100% boundaries(Hunter et al., 2014).12 A sensitivity analysis was performed by 
repeating the meta-analysis after exclusion of studies with a high risk of bias. Statistical analysis was 
performed using MedCalc Version 17.7.2., Belgium. MedCalc uses the Freeman-Tukey (arcsine 
square root) transformation. 
 
 
  
 RESULTS 
 The search strategy yielded 10,391 articles in Pubmed and EMBASE. After screening the 
abstracts, 101 articles were selected and their full-texts were assessed for eligibility. Amongst those 
articles, 96 were excluded. A detailed schematic of the reason for exclusion can be seen in the 
PRISMA diagram (Figure 1 and Appendix 2). In total, we contacted 21 sets of authors for clarification 
about study inclusion / exclusion criteria. All but three answered our emails.  
A total of five studies (4,080 GCS 15, anticoagulated patients) were included in the final 
meta-analysis(Smits et al., 2007; Menditto et al., 2012; Nishijima et al., 2012.; Versmée et al., 2017; 
Mason et al., 2017) from the Netherlands, France, Italy, USA and UK (Table I). All authors supplied 
data for GCS 15 patients. All papers in the analysis were prospective studies evaluating unselected 
patients who presented to an ED with a head injury. All studies included patients who were taking 
vitamin-K antagonists, while one study included 60 patients taking a DOAC and 10 patients 
prescribed enoxaparin(Versmée et al., 2017). 
 The studies differed in their diagnostic protocols with three requiring every patient to have a 
CT(Smits et al., 2007; Menditto et al., 2012; Versmée et al., 2017)  and two leaving this to the 
physicians ? discretion(Nishijima et al., 2012.; Mason et al., 2017). The studies also differed in their 
patient follow up. One study did not perform further CT scans or observe the patients(Smits et al., 
2007). Follow up in the other studies consisted of 24-hour observation with the offer of a repeat 
CT(Versmée et al., 2017), 14-day telephone call(Nishijima et al., 2012), repeat CT with 30-day chart 
review(Menditto et al., 2012)  and 10-week institutional electronic medical record review(Mason et 
al., 2017). No studies reported on repeat head injury during the follow up period. 
 Studies differed in their primary outcome. All studies included ICH (epidural, subdural, 
subarachnoid, intracerebral, intraventricular bleeding or contusion) in their primary outcome. One 
study(Menditto et al., 2012) also included skull fracture in their primary outcome definition. 
 All the studies demonstrated a low risk of bias with respect to the first domain, with 
consecutive ED patients.  Two studies did not perform head CTs in every patient(Nishijima et al., 
 2012.; Mason et al., 2017). One of these studies(Mason et al., 2017) did not perform personal follow 
up on those who did not have a CT, other than electronic medical record review. The risk of bias 
review can be seen in Table II.  
  In total, there were 209 patients among the 4,080 anticoagulated patients who were 
diagnosed with intracranial bleeding. One hundred and eighty-nine patients were diagnosed at 
presentation and twenty during follow up (see Table I). The meta-analysis demonstrated significant 
heterogeneity between studies (I2= 93%). The Forest plot seen in Figure 2 demonstrates a random 
effects incidence of ICH of 8.9% (95% CI 5.0-13.8%) amongst GCS 15 anticoagulated patients with 
head injury. A sensitivity analysis excluding studies with a high risk of bias, the random effects 
incidence of ICH was 10.9% (95% CI 4.6-19.6%).  
 DISCUSSION  
We set out to identify the incidence of ICH in anticoagulated patients with minor head injury 
who have a GCS of 15. The meta-analysis found the incidence to be 9%, with significant 
heterogeneity between studies.  
This is the first meta-analysis to address this question. Two recent meta-analyses reported a 
very low rate of delayed ICH in anticoagulated head injured patients with a normal head CT scan 
(Chauny et al., 2016; Verschoof et al., 2017). These meta-analyses did not report on the incidence of 
ICH at evaluation in the ED. Our analysis included both initial and delayed diagnosis of intracranial 
bleeding among patients with GCS of 15 at triage. 
Two studies by Nishijima et al. and Mason et al. contributed 3545/4080 (87%) of the 
patients. Both studies reported a similar 4% incidence of ICH in anticoagulated GCS 15 head injured 
patients. The three smaller studies by Menditto et al., Versmée et al. and Smits et al. (accounting for 
535/4080 [13%] patients), reported the incidence of ICH to be 22%, 9% and 13% respectively. There 
are several differences between the studies which could explain this difference. Neither of the larger 
studies performed CT scans on all patients with Mason et al. performing CT scans in only 58%. 
However, their follow up showed that only 4/2757 without a diagnosis of ICH at presentation (0.1%) 
were treated for ICH within the following 10 weeks. The three smaller studies performed CT scans on 
every patient, and Menditto et al. and Versmée et al. repeated the CT scan 24 hours later. It is likely 
that these studies diagnosed sub-clinical ICH. We do not know whether such bleeding would become 
a later threat to life. If similar bleeds were missed in the study by Mason et al. their chart review 
suggested that few patients required intervention within 10 weeks.  
All studies included subdural, epidural, subarachnoid, intracerebral, and intraventricular 
bleeding in their primary outcome, as well as cerebral contusion. Menditto et al. was the only study 
to include skull fracture in the primary outcome, which may also have contributed to their high 
primary outcome incidence (22%). dŚĞŵĞĐŚĂŶŝƐŵŽĨŝŶũƵƌǇǀĂƌŝĞĚďǇƐƚƵĚǇǁŝƚŚ ? ?A?ŽĨDĞŶĚŝƚƚŽ ?Ɛ
 study having had a motor vehicle accident. In contrast, the most common mechanism of injury for 
Mason et al. and Nishijima et al. was falling on level ground. 
Our study has several limitations. Only five studies were included in the analysis. More 
studies would allow a more robust understanding of the topic at hand and might improve the 
generalizability of our findings. Our findings may not be applicable to the current clinical setting, 
because almost all of the included patients in this review were prescribed vitamin K antagonists. This 
is at odds with contemporary anticoagulation prescribing(Weitz et al., 2015). We do not report the 
bleeding location, severity or resultant disability. It is, however, reasonable to consider all 
intracranial bleeding to be clinically relevant because current clinical practice is to hold 
anticoagulation, even with small bleeds, along with follow up CT. An individual patient meta-analysis 
would provide information on the associations with diagnosis of intracranial bleeding in these 
patients, however data collection varied between studies which limited the additional benefit of 
such an analysis. 
We have identified an important evidence gap in the literature since a growing proportion of 
anticoagulated patients are prescribed DOACs(Weitz et al., 2015). There is compelling evidence that 
DOACs are associated with a lower risk of ICH compared to warfarin(Sardar et al., 2013; Miller et al., 
2012), although there is sparse data focusing on traumatic intracranial bleeding.  
 The incidence of ICH reported in similar studies of the non-anticoagulated population is 
between 4%- 7%(Barnes et al., 2015; Albers et al., 2013). This review found overall a higher 
incidence among GCS 15 anticoagulated patients, although there were differences between our 
included studies. UK Nice guidance recommends CT scanning in all anticoagulated patients with 
minor head injury, regardless of symptoms, as does the Centers for Disease Control and Prevention 
and American College of Emergency Physicians. A UK economic analysis reported a £94,895 cost per 
additional quality adjusted life year (QALY) when CT scanning all patients, compared to 
contemporary practice(Kuczawski et al., 2016). This is more than three times the UK threshold of 
cost effectiveness which raises the question of whether a selective CT scan protocol is required. 
   Ours is the first systematic review on this topic which lends support to the concept that 
patients prescribed anticoagulation may have a higher risk of ICH. Our findings might support 
implementation of a selective CT scanning policy. As yet, there has been no study to assess such an 
approach and we lack data for DOAC use. Since the majority of anticoagulated patients are older, 
and there are a growing number of elderly presenting to the ED following a fall, future studies on 
this population should be a priority among both funders and researchers. Without robust data, we 
will be unable to align our diagnostic practice appropriately to identify both immediate and delayed 
traumatic anticoagulated ICH.  
 In summary, we found a 9% incidence of ICH in anticoagulated, GCS 15, head injured 
patients (almost exclusively prescribed vitamin K antagonists). We recommend that future studies 
collect prospective data on patients prescribed all forms of anticoagulation and evaluate the safety 
of a selective CT scanning approach. 
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